Toward a better understanding of the relationship between docosahexaenoic acid and bronchopulmonary dysplasia and the questions that remain.

Bazinet RP(1), Laye S(2).

Author information:
(1)Department of Nutritional Sciences, University of Toronto, Toronto, Ontario,
Canada. Electronic address: .
(2)INRAE, Bordeaux INP, NutriNeuro, Université de Bordeaux, Bordeaux, France.

DOI: 10.1016/j.ajcnut.2025.01.030
PMID: 40000261

Conflict of interest statement: Conflict of interest R.P.B. has received
industrial grants, including those matched by the Canadian government, and/or
travel support from Arctic Nutrition, Bunge Ltd., DSM, The Dairy Farmers of
Canada, Mead Johnson, Natures Crops International, Nestec Inc, Pharmavite, and
Sansero Life Sciences Inc. R.P.B. has served as a consultant to Bunge Ltd.,
Fonterra, and Red Abbey Labs. Moreover, R.P.B. was on the executive committee of
the International Society for the Study of Fatty Acids and Lipids and held a
meeting on behalf of fatty acids and cell signaling, both of which rely on
corporate sponsorship. R.P.B. has given expert testimony in relation to
supplements and the brain. The other author reports no conflicts of interest.

Auteurs Bordeaux Neurocampus